Next Test in Primary Sclerosing Cholangitis
Perform ileocolonoscopy with biopsies from all colonic segments including the terminal ileum at the time of PSC diagnosis, regardless of whether visible lesions are present. 1
Rationale for Colonoscopy as the Next Test
The most critical next step after diagnosing PSC is screening for inflammatory bowel disease (IBD), which has profound implications for mortality and quality of life:
Ileocolonoscopy with biopsies is strongly recommended at PSC diagnosis to detect IBD, which is present in up to 88% of PSC patients 1, 2
Biopsies must be obtained from all colonic segments and the terminal ileum, even when the mucosa appears normal endoscopically, as microscopic inflammation may be present 1
This screening directly impacts mortality risk because PSC-IBD patients have significantly increased risk of colorectal cancer, requiring annual surveillance colonoscopy 1, 3
Additional Essential Surveillance Tests
Beyond the initial colonoscopy, establish a comprehensive surveillance program:
Cancer Surveillance (Every 6-12 Months)
Cross-sectional imaging (ultrasound, CT, or MRI) with or without CA 19-9 should be performed every 6-12 months for cholangiocarcinoma and gallbladder cancer surveillance 3
This surveillance is particularly critical in the first year after diagnosis, when 27-37% of cholangiocarcinomas are detected 3
MRI/MRCP is preferred over ERCP for routine surveillance imaging, as ERCP should be reserved for therapeutic interventions 4, 5
Ongoing IBD Surveillance
Annual colonoscopy (or every 1-2 years in selected patients) is required for all adult PSC-IBD patients regardless of IBD duration or liver transplant status 1
Colonoscopy every 5 years can be considered in PSC patients without IBD, or whenever symptoms suspicious for IBD develop 1
When to Perform ERCP
Do not use ERCP routinely for surveillance 3. Reserve ERCP with brush cytology and endobiliary biopsies for specific clinical scenarios:
- Worsening clinical symptoms or cholestasis 3, 4
- New or progressive dominant stricture on imaging 1, 4
- Suspected cholangiocarcinoma based on imaging findings or elevated CA 19-9 1, 4
- Therapeutic intervention for clinically relevant strictures 1
Critical Pitfalls to Avoid
Never skip the initial colonoscopy even if the patient has no GI symptoms—microscopic IBD is common and changes management 1
Avoid routine ERCP for surveillance—it carries procedural risks without proven benefit for routine monitoring 3
Do not delay cancer surveillance—the highest risk period is the first year after PSC diagnosis 3
Remember that normal-appearing mucosa does not exclude IBD—biopsies are mandatory 1